You’ve likely seen the claims:
“We reversed brain damage with hyperbaric oxygen!”
“HBOT gave our child a second chance!”
“This is the miracle therapy your neurologist won’t tell you about!”
When your child has a diagnosis like HIE or cerebral palsy, and the medical team tells you there are no guarantees—or worse, no further treatments—it's only natural to keep searching.
But is Hyperbaric Oxygen Therapy (HBOT) a safe, effective and legitimate treatment for pediatric brain injury? Or is it another example of hype that overpromises and underdelivers? It seems to make sense on the surface, wouldn't pressurized oxygen at 100% be good for a hypoxic brain injury? Let's talk about it.
Hyperbaric Oxygen Therapy (HBOT) is a medical treatment where a person breathes 100% oxygen in a pressurized chamber, typically 1.5 to 3 times the normal atmospheric pressure. This increases the amount of oxygen carried in the blood, which may support healing in certain injuries or infections.
HBOT is legitimately used worldwide, but only for specific, well-researched conditions. Regulatory agencies across countries have approved HBOT for a narrow list of indications.
| Country/Region | Approved HBOT Indications | Regulatory Body |
|---|---|---|
| United States | 14 approved conditions (e.g. carbon monoxide poisoning, gas embolism, diabetic foot ulcers, radiation injury) | FDA, Undersea & Hyperbaric Medical Society (UHMS) |
| Canada | Similar to U.S.; use limited to hospital-based settings for specific conditions | Health Canada |
| UK | Approved for decompression illness, gas embolism, soft tissue infections, etc. | NHS, British Hyperbaric Association |
| Australia | Approved for radiation injury, crush injuries, diabetic wounds | Therapeutic Goods Administration (TGA) |
| Europe (varies) | Some countries allow more flexible “off-label” use, but HIE and CP are not recognized indications by EMA or national agencies | European Medicines Agency (EMA) and national regulators |
✅ Nowhere in the world is HBOT officially approved to treat cerebral palsy or hypoxic-ischemic encephalopathy (HIE).
⚠️ HBOT is not approved by any regulatory agency worldwide for treating cerebral palsy (CP) or neonatal hypoxic-ischemic encephalopathy (HIE)—but it is often marketed for these conditions without sufficient evidence or oversight.
“HBOT heals damaged brain tissue.”
“It’s natural, safe, and worth trying.”
“It worked for someone else’s child—why not yours?”
Many private clinics, social media influencers, and alternative therapy networks promote HBOT directly to families, especially for cerebral palsy and HIE. These claims are not supported by rigourous science, and they take advantage of gaps in research and the emotional vulnerability of families facing lifelong diagnoses.
Iona Novak’s research, including her systematic reviews and the “State of the Evidence Traffic Lights 2019,” classifies hyperbaric oxygen therapy (HBOT) as ineffective for improving motor function in children with cerebral palsy and recommends against its use due to lack of benefit and potential for harm, such as hearing loss and pain. This assessment is supported by the most recent high-quality randomized controlled trials and systematic reviews, which consistently show that HBOT does not provide greater improvements in motor or cognitive outcomes compared to pressurized air or standard therapies. Both HBOT and control groups typically show similar improvements, likely reflecting natural progression or placebo effects.
The largest multicenter RCT found no difference in gross motor function between HBOT and slightly pressurized air, with both groups improving modestly and similarly over the study period. Adverse events, particularly middle ear barotrauma, are more frequent with HBOT but are generally mild. Recent meta-analyses and systematic reviews confirm these findings and highlight the moderate evidence for increased adverse events with HBOT compared to controls.
While some re-analyses using the Gross Motor Function Measure Evolution Ratio (GMFMER) suggest greater progress with HBOT, these findings are confounded by methodological limitations and lack of appropriate controls.
Key Takeaways:
📚 Sources: [1,3,5,8–9]
No ongoing or recently completed high-quality randomized controlled trials registered in major trial registries have demonstrated efficacy or safety of hyperbaric oxygen therapy (HBOT) for neonatal hypoxic-ischemic encephalopathy (HIE). For neonatal HIE, most clinical trials have been small, single-center studies with poor methodological quality and limited reporting. While some meta-analyses suggest HBOT may reduce mortality and neurological sequelae, these findings are undermined by lack of standardized protocols, inadequate randomization, absence of blinding, and insufficient long-term follow-up. No recent high-quality, CONSORT-adherent randomized controlled trials have established HBOT as effective or safe for neonatal HIE. The only intervention with robust evidence and guideline support for improving outcomes in neonatal HIE is therapeutic hypothermia.
📚 Sources: [2–4,6–7,10–12]
HBOT is often marketed as “natural” or “non-invasive,” but it carries documented risks, especially in neurologically fragile children.
Fact: HBOT is linked to more side effects than standard treatments. The most common problem is middle ear barotrauma, which means pain or injury to the ear from pressure changes. This can happen in up to half of children receiving HBOT. Other side effects include ear discomfort, the need for ear tubes, and, less commonly, seizures. Mechanistically, HBOT can increase reactive oxygen species and alter neurotransmitter balance, lowering the seizure threshold.
The American Academy of Pediatrics and other experts highlight these risks and recommend against HBOT.
📚 Sources: [1,4,5,11]
Across most healthcare systems—public or private—HBOT is not covered for HIE or CP because:
In many countries, HBOT for CP or HIE is only offered in private clinics, often at $100–300 per session, with 20–40 sessions recommended—fully out-of-pocket.
Real hope lies in treatments that are:
These include:
Connect with families, read inspiring stories, and get helpful resources delivered right to your inbox.
Connect with families, read inspiring stories, and get helpful resources delivered right to your inbox.
